Literature DB >> 6247749

Specific receptors for prostaglandins in airways.

P J Gardiner, H O Collier.   

Abstract

The relative bronchomotor activities of prostaglandins (PG) E1, E2, F2 alpha, F2 beta and I2 and of three synthetic E prostaglandin analogues (TR4161, TR4367 and TR4752) were determined on a large number of isolated preparations of guinea-pig trachea and human bronchial muscle. Each prostaglandin was capable of eliciting both contraction and relaxation, the relative incidence of these responses partly depending on concentration. TR4161 was a virtually pure relaxant; TR4367 was virtually devoid of bronchomotor activity; and TR4752 was a potent relaxant, devoid of contractant activity. The results also provided distinct rank orders of approximate potency for contraction and relaxation. Tachyphylaxis to the relaxant activities of PGE1 and TR4752 confirmed the underlying contractant activity of the two natural E prostaglandins. Antagonism with a high dose of indomethacin of the contractant actions of PGE1, PGE2 and PGF2 alpha confirmed the presence of relaxant activities in each. Inhaled aerosols of the same natural and synthetic prostaglandins were evaluated for irritant activity on the airways, using the cough response of the restrained conscious cat. All of them, except TR4161, elicited severe coughing. The rank order of potencies for irritancy differed from those for tracheobronchial contractant and relaxant activities. These findings suggest that the three responses studied arise from the activation of three distinct PG receptors in the airways. We propose the terms chi (contractant), psi (relaxant) and omega (irritant) for these putative receptors for prostaglandins or possibly other prostanoids.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6247749     DOI: 10.1016/0090-6980(80)90116-1

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  25 in total

Review 1.  Airway receptors.

Authors:  P J Barnes
Journal:  Postgrad Med J       Date:  1989-08       Impact factor: 2.401

Review 2.  Prostaglandins and the lung.

Authors:  S P Hanley
Journal:  Lung       Date:  1986       Impact factor: 2.584

3.  Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues.

Authors:  Y J Dong; R L Jones; N H Wilson
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

4.  Proceedings of the Fiftieth Anniversary Meeting of the British Pharmacological Society, University of Oxford, 16-18 September 1981. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1981-12       Impact factor: 8.739

5.  In vivo allergen tachyphylaxis in guinea pig lung is mediated by endogenous prostaglandin E biosynthesis.

Authors:  W Dorsch; L Frey; W Müller
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-03       Impact factor: 3.000

6.  Studies on L-640,035: a novel antagonist of contractile prostanoids in the lung.

Authors:  R Carrier; E J Cragoe; D Ethier; A W Ford-Hutchinson; Y Girard; R A Hall; P Hamel; J Rokach; N N Share; C A Stone
Journal:  Br J Pharmacol       Date:  1984-06       Impact factor: 8.739

7.  [Aerosolized and intravenous prostacyclin during one-lung ventilation. Hemodynamic and pulmonary effects].

Authors:  M Bund; D Henzler; R Walz; R Rossaint; S Piepenbrock; R Kuhlen
Journal:  Anaesthesist       Date:  2004-07       Impact factor: 1.041

8.  Antagonism of prostanoid-induced contractions of rat gastric fundus muscle by SC-19220, sodium meclofenamate, indomethacin or trimethoquinol.

Authors:  A Bennett; C Jarosik; G J Sanger; D E Wilson
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

9.  Purification of haptoglobin and its effects on lymphocyte and alveolar macrophage responses.

Authors:  M W Baseler; R Burrell
Journal:  Inflammation       Date:  1983-12       Impact factor: 4.092

10.  Inhibitory effects of BAY u3405 on prostanoid-induced contractions in human isolated bronchial and pulmonary arterial muscle preparations.

Authors:  X Norel; C Labat; P J Gardiner; C Brink
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.